Towa Pharmaceutical Co., Ltd. 6QC.F Stock
Towa Pharmaceutical Co., Ltd. Price Chart
Towa Pharmaceutical Co., Ltd. 6QC.F Financial and Trading Overview
| Towa Pharmaceutical Co., Ltd. stock price | 17 EUR |
| Previous Close | 11.5 EUR |
| Open | 11.4 EUR |
| Bid | 11.4 EUR x N/A |
| Ask | 11.6 EUR x N/A |
| Day's Range | 11.4 - 11.4 EUR |
| 52 Week Range | 11.4 - 19.5 EUR |
| Volume | 30 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 563.72M EUR |
| Beta (5Y Monthly) | 0.248275 |
| PE Ratio (TTM) | 30 |
| EPS (TTM) | 1.45 EUR |
| Forward Dividend & Yield | 0.4 (3.42%) |
| Ex-Dividend Date | September 28, 2023 |
| 1y Target Est | N/A |
6QC.F Valuation Measures
| Enterprise Value | 149.38B EUR |
| Trailing P/E | 30 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.002699028 |
| Price/Book (mrq) | 0.004099003 |
| Enterprise Value/Revenue | 0.715 |
| Enterprise Value/EBITDA | 5.994 |
Trading Information
Towa Pharmaceutical Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 0.248275 |
| 52-Week Change | -25.94% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 19.5 EUR |
| 52 Week Low | 11.4 EUR |
| 50-Day Moving Average | 12.71 EUR |
| 200-Day Moving Average | 14 EUR |
6QC.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 49.22M |
| Float | 24.57M |
| Short Ratio | N/A |
| % Held by Insiders | 47.95% |
| % Held by Institutions | 18.20% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 60 |
| Trailing Annual Dividend Yield | 521.73% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 1.0777 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 1.05% |
| Operating Margin (ttm) | 2.64% |
| Gross Margin | 34.81% |
| EBITDA Margin | 11.93% |
Management Effectiveness
| Return on Assets (ttm) | 0.98% |
| Return on Equity (ttm) | 1.63% |
Income Statement
| Revenue (ttm) | 208.86B EUR |
| Revenue Per Share (ttm) | 4243.22 EUR |
| Quarterly Revenue Growth (yoy) | 71.09% |
| Gross Profit (ttm) | 72.71B EUR |
| EBITDA | 24.92B EUR |
| Net Income Avi to Common (ttm) | 2.2B EUR |
| Diluted EPS (ttm) | 0.38 |
| Quarterly Earnings Growth (yoy) | -76.29% |
Balance Sheet
| Total Cash (mrq) | 24.26B EUR |
| Total Cash Per Share (mrq) | 492.81 EUR |
| Total Debt (mrq) | 173.06B EUR |
| Total Debt/Equity (mrq) | 126.42 EUR |
| Current Ratio (mrq) | 2.33 |
| Book Value Per Share (mrq) | 2781.164 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 2.54B EUR |
| Levered Free Cash Flow (ttm) | -27054999552 EUR |
Profile of Towa Pharmaceutical Co., Ltd.
| Country | Germany |
| State | N/A |
| City | Osaka |
| Address | 2-11, Shinbashi-cho |
| ZIP | 571-8580 |
| Phone | 81 6 6900 9100 |
| Website | https://www.towayakuhin.co.jp |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It had a portfolio of approximately 700 products. The company was founded in 1951 and is headquartered in Osaka, Japan.
Q&A For Towa Pharmaceutical Co., Ltd. Stock
What is a current 6QC.F stock price?
Towa Pharmaceutical Co., Ltd. 6QC.F stock price today per share is 17 EUR.
How to purchase Towa Pharmaceutical Co., Ltd. stock?
You can buy 6QC.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Towa Pharmaceutical Co., Ltd.?
The stock symbol or ticker of Towa Pharmaceutical Co., Ltd. is 6QC.F.
Which industry does the Towa Pharmaceutical Co., Ltd. company belong to?
The Towa Pharmaceutical Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Towa Pharmaceutical Co., Ltd. have in circulation?
The max supply of Towa Pharmaceutical Co., Ltd. shares is 49.58M.
What is Towa Pharmaceutical Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Towa Pharmaceutical Co., Ltd. PE Ratio is 11.72413700 now.
What was Towa Pharmaceutical Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Towa Pharmaceutical Co., Ltd. EPS is 1.45 EUR over the trailing 12 months.
Which sector does the Towa Pharmaceutical Co., Ltd. company belong to?
The Towa Pharmaceutical Co., Ltd. sector is Healthcare.